Article contents
Tap any item to jump directly to the section you need.
Straumann® SLActive® – The Swiss Hydrophilic Implant Surface Designed for Faster Healing
When considering dental implant treatment, many patients focus on the implant brand or implant material. However, another key factor plays an equally important role in treatment success: the implant surface.
Straumann® SLActive® is an advanced implant surface technology developed in Switzerland to promote faster healing and support efficient osseointegration. It has become one of the defining innovations behind Straumann’s global reputation in implant dentistry.
What Is a Hydrophilic Implant Surface?
Many conventional implant surfaces tend to repel liquids. In contrast, SLActive® is specifically designed to be hydrophilic, meaning it attracts blood and biological fluids immediately after implant placement.
This creates a favorable environment for the early stages of healing and bone formation around the implant.
Why Does Hydrophilicity Matter?
Successful implant treatment depends on osseointegration—the process through which bone bonds to the implant surface.
According to Straumann, SLActive® can reduce the initial healing period to approximately 3–4 weeks.
For patients, this may provide several advantages:
Faster healing support
Earlier treatment progression
Increased implant stability during early healing
Improved overall treatment experience
More Than Hydrophilicity
SLActive® offers benefits beyond simply attracting fluids.
Research has identified unique nanostructures on the SLActive® surface that are not present on conventional implant surfaces. These nanostructures increase surface area by more than 50% and support fibrin network formation as well as bone cell mineralization during the early healing phase.
In simple terms, the surface is designed to help the body establish a stronger biological connection with the implant.
Backed by 20 Years of Clinical Evidence
Advanced technology must be supported by long-term clinical validation.
Straumann reports that SLActive® has accumulated 20 years of documented clinical success worldwide.
In immediate loading protocols, where restorations are delivered shortly after implant placement, SLActive® demonstrated a 10-year implant survival rate of 98.2%.
These results highlight the predictability and long-term reliability of the technology.
Performance in Challenging Conditions
SLActive® has also demonstrated strong performance in demanding clinical situations.
Published studies referenced by Straumann have shown positive outcomes in patients with diabetes, smokers, and other compromised patient groups where healing may be more challenging.
This helps expand treatment possibilities for a broader range of patients.
Swiss Innovation for Long-Term Confidence
Developed in Switzerland, Straumann® SLActive® reflects decades of research in implant surface science, bone biology, and healing optimization.
The technology is designed not only to accelerate healing but also to support predictable long-term implant success. For patients seeking a scientifically proven implant solution, SLActive® represents one of the most advanced implant surface technologies available today.